Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HLA-DMA |
| Upstream (Parents) |
|---|
| (<<) CD74 → HLA-DMA |
| (<<) HLA-DMB → HLA-DMA |
| (<<) CD86 → HLA-DMA |
| Downstream (Children) |
|---|
| HLA-DMA → PSMB9 (>>) |
| HLA-DMA → CRTAM (>>) |
| HLA-DMA → GFI1 (>>) |
| HLA-DMA → CAB39L (>>) |
| HLA-DMA → GM2A (>>) |
| HLA-DMA → SIGLEC9 (>>) |
| HLA-DMA → SLAMF7 (>>) |
| HLA-DMA → APOBEC3G (>>) |
| HLA-DMA → CFD (>>) |
| HLA-DMA → HLA-DMB (>>) |
| HLA-DMA → UCP2 (>>) |
